Results
1 -
10 of
17
(Click
here to explore results)
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 1 Privileged Scaffolds in Medicinal Chemistry: An Introduction. Eliezer J. Barreiro
, 2016
, Pages 1-15
- Green Synthetic Processes and Procedures, CHAPTER 3 Application of Step, Cumulative, and Global E-factor and Process Mass Intensity Metrics to Gauge Synthesis Efficiency: l-DOPA and Apixaban Pharmaceutical Examples. John Andraos
, 2019
, Pages 39-52
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection. Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
- Drug Design Strategies: Quantitative Approaches, Chapter 5 Contribution of Structure-Based Drug Design to the Discovery of Marketed drugs. Alexander A. Alex, David S. Millan
, 2012
, Pages 108-163
- Green Synthetic Processes and Procedures, Contents
, 2019
, Pages P009-P017
- The Handbook of Medicinal Chemistry: Principles and Practice, CHAPTER 1 Physicochemical Properties and Compound Quality. M. Paul Gleeson, Paul D. Leeson, Han van de Waterbeemd
, 2015
, Pages 1-31
- Synthetic Methods in Drug Discovery: Volume 1, Chapter 7 Chan–Lam Coupling Reaction: Copper-promoted C–Element Bond Oxidative Coupling Reaction with Boronic Acids. Patrick Y. S. Lam
, 2016
, Volume 1
, Pages 242-273
- Synthetic Methods in Drug Discovery: Volume 2, Subject Index
, 2016
, Volume 2
, Pages 505-517
- Synthetic Methods in Drug Discovery: Volume 1, Subject Index
, 2016
, Volume 1
, Pages 443-455
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Subject Index
, 2016
, Pages 459-468